G9649 HCPCS code: Psoriasis assessment tool documented meeting any one of the specified benchmarks (e.g., (pga; 5-point or 6-point scale), body surface area (bsa), psoriasis area and severity index (pasi) and/or dermatology life quality index) (dlqi))
G9649 is the HCPCS Level II code for psoriasis assessment tool documented meeting any one of the specified benchmarks (e.g., (pga; 5-point or 6-point scale), body surface area (bsa), psoriasis area and severity index (pasi) and/or dermatology life quality index) (dlqi)). Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case.
Code details
| Field | Value |
|---|---|
| Section | G codes — Procedures and professional services (temporary) |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 00 — Not separately priced by Medicare |
| BETOS category | Z2 |
| Added | 2016-01-01 |
| Last action effective | 2019-01-01 |
What changed for G9649
- 2016-01-01: G9649 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code G9649?
G9649 is the HCPCS Level II code for psoriasis assessment tool documented meeting any one of the specified benchmarks (e.g., (pga; 5-point or 6-point scale), body surface area (bsa), psoriasis area and severity index (pasi) and/or dermatology life quality index) (dlqi)). Short descriptor: "Psor as doc spc bm".
Does Medicare cover G9649?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
Related G96 codes
- G9600 — Symptomatic aaas that required urgent/emergent (non-elective) repair
- G9601 — Patient discharge to home no later than post-operative day #7
- G9602 — Patient not discharged to home by post-operative day #7
- G9603 — Patient survey score improved from baseline following treatment
- G9604 — Patient survey results not available
- G9605 — Patient survey score did not improve from baseline following treatment
- G9606 — Intraoperative cystoscopy performed to evaluate for lower tract injury
- G9607 — Documented medical reasons for not performing intraoperative cystoscopy (e.g., urethral pathology precluding cystoscopy, any patient who has a congenital or acquired absence of the urethra) or in the case of patient death
- G9608 — Intraoperative cystoscopy not performed to evaluate for lower tract injury
- G9609 — Documentation of an order for anti-platelet agents
- G9610 — Documentation of medical reason(s) in the patient's record for not ordering anti-platelet agents
- G9611 — Order for anti-platelet agents was not documented in the patient's record, reason not given
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under G9649
- Watch G9649 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for G9649
Sources: CMS HCPCS Level II release October 2026; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.